ServiziMenu principaleHome
You are here:  > Educational Opportunities > Future Events > Refresher course in melanoma surgery
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Refresher course in melanoma surgery

9 ESCO credits

11.10.2024  -  13.10.2024

Dublin, Ireland




Chairs:  R. Olofsson Bagge, SE - R. Audisio, SE


The refresher course on melanoma surgery has been designed for surgical and medical oncologists with the aim to provide a comprehensive update concerning modern treatment for melanoma, as well as an overview of the latest advances in the field. Practical training will be offered in the frame of collegial discussions with participants and the faculty, a multidisciplinary conference, but also video presentations of common surgical techniques.

Attendance to the course is limited and by application only.

  • Understand melanoma biology, epidemiology and pathology
  • Update on treatment options for wide local excisions and basic flaps
  • Update on sentinel node biopsy and lymph node dissections, including videos
  • Learn about modern systemic targeted treatment and immunotherappy
  • Learn about the role of adjuvant and neoadjuvant systemic treatment
  • Learn about locoregional treatments including isolated limb perfusion, isolated limb infusion, electrochemotherapy and TVEC
  • Learn about the role of surgery in metastatic disease
  • Learn about the future development in the treatment of melanoma
  • Debate controversies and challenges in melanoma care
  • Improve practical skills in multidisciplinary management and follow-up of patients with melanoma



The official language will be English. No translation will be available.


The Refresher Course in Melanoma Surgery is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

It has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 10 European CME credits (ECMEC®s).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credits to AMA credits can be found here.

Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

ESCO - The ESO College

Being selected to take part in this ESO activity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
This event also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the event earns participants 9 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.


Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO masterclass.

Applicants should meet the following profile:

  • Age between 30 and 45 years
  • At least 2-3 years’ experience in oncology
  • Fluency in English

Successful applicants are granted free registration.

Accommodation at for arrival on the 11th October and departure on the 13th October will be provided to participants not residing in the Dublin area.


Mariachiara Deleo
European School of Oncology (ESO)
Via Turati 29
IT- 20121 Milan

ph  +39 335 181 4541
email: mdeleo@eso.net


Dolores Knupfer
European School of Oncology (ESO)
Via Vicenzo Vela 6
CH- 6500 Bellinzona

ph +41 91 820 09 52
e-mail: dknupfer@eso.net


11 October


12 October

8:15Transfer to venue
Riccardo A. Audisio, IT - Roger Olofsson Bagge , SE
9:00Melanoma biology
Jens Rauch , IE
Karolin Isaksson, SE
Aurelie Fabre, IE
10:45Primary excision, WLE and flaps
Marc Moncrieff, UK
Marc Moncrieff, UK
12:15Lunch with faculty discussion
13:15Lymph node dissections
Dirk Grünhagen, NL
13:45LND videos of H&N, axillary, inguinal, iliac
Dirk Grünhagen, NL - Marc Moncrieff, UK - Roger Olofsson Bagge , SE - Piotr Rutkowski, PL - Winan van Houdt, NL
15:15Targeted therapies
John Crown, IE
John Crown, IE
15:55Adjuvant treatment
Piotr Rutkowski, PL
16:15Neoadjuvant treatment
Piotr Rutkowski, PL
16:35Patient advocacy
Mark Lawler, UK
16:55Data and digital health
Mark Lawler, UK

13 October

8:00Transfer to venue
Julie Gehl, DK
9:00TILs therapy
Winan van Houdt, NL
Winan van Houdt, NL
Winan van Houdt, NL
10:45Surgery for metastatic disease
Dirk Grünhagen, NL
11:15Debate: The future of melanoma treatment - All faculty members
Dirk Grünhagen, NL
11:45MDT discussion - All faculty members
Dirk Grünhagen, NL
12:30What ESO has done for me
Alvin Lee, UK
12:45Closing remarks and course evaluation -All faculty members


Riccardo A. Audisio, Gothenburg University, Department of Surgery, Gothenburg, Sweden
John Crown, St Vincent's University Hospital, Dept of Medical Oncology, Dublin, IE
Aurelie Fabre, St Vincent's University Hospital, Oncology Department, Dublin, IE
Julie Gehl, University of Copenhagen, Department of Clinical Medicine, Copenhagen, DK
Dirk Grünhagen, Erasmus Medical Center, Oncology Department, Rotterdam, NL
Karolin Isaksson, Department of Surgery Kristianstad Hospital, Kristianstad, Sweden and Lund University, Lund, Sweden
Mark Lawler, Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Alvin Lee, London, UK
Marc Moncrieff, Norfolk and Norwich University Hospital, Plastic ann reconstructive surgery, Norwich, UK
Roger Olofsson Bagge, Gothenburg University, Department of Surgery, Gothenburg, SE
Jens Rauch, University College Dublin, School of Biomolecular and Biomedical Science, Systems Biology, Dublin, IE
Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Winan van Houdt, National Cancer Institute, Surgical Oncology Dept, Amsterdam, NL


Application deadline 16th August 2024

Interested candidates should apply before 16th August online providing:

  • Application template
  • Motivation letter
  • Short CV (template) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)

If you are a past ESO Masterclass participant, you only need to submit the application template.